Form 4: Sight Sciences CEO Sells Shares to Cover Tax Obligations

Sight Sciences CEO, Paul Badawi, sold 12,236 shares of common stock to cover tax liabilities related to vesting restricted stock units.

Summary

• Paul Badawi, the President and CEO of Sight Sciences, Inc., sold 12,236 shares of common stock on January 2, 2025.
• The sale was executed to cover tax obligations arising from the vesting of restricted stock units.
• The shares were sold at a weighted average price of $3.597 per share.
• The sale occurred in multiple transactions with prices ranging from $3.55 to $3.67 per share.
• Following the transaction, Mr. Badawi beneficially owns 5,713,197 shares of Sight Sciences common stock.

Sentiment

Score: 5

Explanation: The document describes a routine transaction for an executive to cover tax obligations. It is neither positive nor negative for the company's outlook.

Industry Context

This is a routine transaction for executives who receive stock-based compensation. It is common for executives to sell shares to cover tax obligations when restricted stock units vest.

Comparison to Industry Standards

• Executive stock sales to cover tax obligations are a common practice across publicly traded companies.
• The sale of 12,236 shares is relatively small compared to the total holdings of 5,713,197 shares, suggesting it is a routine tax-related transaction rather than a significant divestment.
• Similar transactions are regularly reported by executives at companies like Alcon, Johnson & Johnson, and Bausch + Lomb, which are also in the eye care sector.

Stakeholder Impact

• The stock sale is unlikely to have a significant impact on shareholders as it is a small percentage of the CEO's total holdings and is for tax purposes.

Key Dates

Keywords

stock sale, insider trading, executive compensation, tax liability, restricted stock units, Sight Sciences, Paul Badawi